# FDA Inspection 1170977 - Octapharma Plasma Inc - April 29, 2022

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/cd764274-ccfd-40ed-b735-f2b92c6f52cd
Source feed: FDA_Inspections

> FDA Inspection 1170977 for Octapharma Plasma Inc on April 29, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1170977
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2022-04-29
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1170977 - 2022-04-29](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/4d1c1561-b456-4d7c-845d-b100170d00bc)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/488cc0ae-1032-4fc2-b52b-da929a974d0b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d